Research ArticlesSynthesis and Dopaminergic Activity of 3-(3,4-Dihydroxyphenyl)-1-n-propylpyrrolidine Hydrobromide

Add time:08/15/2019    Source:sciencedirect.com

3-(3,4-Dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide was synthesized by a six-step reaction sequence and was evaluated, and compared with apomorphine, for central dopaminergic agonist activity. The compound produced behavioral and biochemical changes characteristic of central dopaminergic stimulation. Administration of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide to rats resulted in the reversal of the reserpine syndrome, stereotypic behavior, contralateral turning following 6-hydroxydopamine lesion of the substantia nigra, a decrease in dopamine turnover, and inhibition of prolactin release. These results indicate that 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide is a dopaminergic agonist. However, the compound exhibited a lower potency but a slightly longer duration of action than apomorphine.

We also recommend Trading Suppliers and Manufacturers of 3-PROPYLPYRROLIDINE (cas 116632-47-4). Pls Click Website Link as below: cas 116632-47-4 suppliers

Prev:Research paperChemical effect of no (cas 116632-23-6) on CH4 oxidation during combustion in O2/no (cas 116632-23-6) environments
Next:Synthesis, spectrophotometric characterization and DFT computational study of a novel quinoline derivative, 2-amino-4-(2,4,6-trinitrophenylamino)-quinoline-3-carbonitrile)